Skip to main content
. 2022 Apr 7;102(14):e33468. doi: 10.1097/MD.0000000000033468

Figure 3.

Figure 3.

Prognostic assessment of CDKN2A level in OS and DFS. Kaplan–Meier analysis of OS (A) and DFS (B) in patients with low and high CDKN2A. The low-expression and high-expression cohorts were divided according to the thresholds with low cutoff (50%) and high cutoff (50%) values. P value < .01 and | logFC| > 1 were cutoff values. CDKN2A = cyclin dependent kinase inhibitor 2A, DFS = disease free survival, OS = overall survival.